Korean Cancer Study Group (KCSG) is a nation’s leader in multi-institutional cancer clinical trials.
KCSG has been dedicated to advance clinical and translational cancer research through
multi-institutional clinical trials in Korea since its establishment in 1998.


KCSG: Paving the way to a cancer-free world


  • To design and conduct practice changing clinical trials
  • To promote international collaborative cancer research
  • To optimize multidisciplinary team science in cancer research
  • To implement the education and training on the cutting-edge knowledge in cancer treatment and clinical trials
  • To improve accessibility from the public to cancer clinical trials

Annual Report 2022